Piedmont Atlanta first in Georgia to offer new minimally invasive treatment for emphysema

Zephyr Valve Placement. Credit: Pulmonx

The procedure improves patients' quality of life by allowing them to breathe easier, be less short of breath and be more active and energetic. The treatment, using the Zephyr® Valve System, is groundbreaking because it is the first FDA-approved procedure for emphysema that is minimally invasive, meaning no incision or cutting is required.

“This new treatment option is a life-changer for people with emphysema and severe COPD,” said Ralitza Martin, M.D., an interventional pulmonologist with Piedmont Pulmonary, Critical Care and Sleep Medicine and the first physician in the state to perform this procedure.

“Until now, the only other options for these patients were highly invasive treatments such as surgical lung volume reduction or lung transplantation. This minimally invasive procedure offers new hope for patients who remain symptomatic despite optimal medical care.”

COPD and specifically emphysema is a progressive and life-threatening lung disease usually caused by smoking. There is no cure and patients live with severe shortness of breath. Simple daily activities like walking or taking a shower are often very difficult.

This extreme shortness of breath is caused when air becomes trapped in parts of the lung that are damaged by the disease. This trapped air causes the damaged areas of the lungs to get larger, which puts pressure on the healthy parts of the lungs and diaphragm. This procedure places tiny valves in the airways to block off the damaged areas of the lung so air is no longer trapped there, allowing the healthier parts of the lungs to expand so patients can breathe more easily.

“We've been doing this procedure for several months now and I have seen a dramatic improvement in the quality of life of patients who have been treated,” said Dr. Martin. “It's incredibly rewarding to see patients who were previously unable to walk down a hallway regain the ability to go outside and spend time with family and friends.”

In clinical studies, patients treated with the Zephyr® Valve System have been shown to breathe easier, be more active and energetic, be less short of breath and enjoy a significantly improved quality of life compared to untreated patients.

###

To learn more about the procedure visit pulmonx.com. To determine eligibility for the procedure, contact Piedmont Atlanta's Interventional Pulmonary team at InterventionalPulmonary@piedmont.org or call 404-605-3904.

Media Contact

Meghan K. Oreste
megoreste@gmail.com
617-823-1441

http://www.mylungsmylife.com 

All latest news from the category: Medical Engineering

The development of medical equipment, products and technical procedures is characterized by high research and development costs in a variety of fields related to the study of human medicine.

innovations-report provides informative and stimulating reports and articles on topics ranging from imaging processes, cell and tissue techniques, optical techniques, implants, orthopedic aids, clinical and medical office equipment, dialysis systems and x-ray/radiation monitoring devices to endoscopy, ultrasound, surgical techniques, and dental materials.

Back to home

Comments (0)

Write a comment

Newest articles

Distance learning can improve women’s access to vocational training as animal health care practitioners in Nepal. Image Credit: Heifer International

Hybrid Job Training Boosts Women’s Participation in Nepal

Globally, women’s workforce participation is about 25% lower than men’s, often due to barriers such as domestic responsibilities and cultural norms. Vocational training can increase employment opportunities, but women may…

CO2release increase under repeated drying-rewetting cycles (DWCs). Image Credit: Suzuki, Nagano et al., 2025 SOIL

Drying and Rewetting Cycles Boost Soil CO2 Emissions

Niigata, Japan – The amount of carbon dioxide (CO2) released by microbial decomposition of soil organic carbon on a global scale is approximately five times greater than the amount of…

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers. Oregon State's Olena Taratula and collaborators including OSU postdoctoral researcher Babak Mamnoon and Maureen Baldwin, a physician at Oregon Health & Science University, designed a type of drug nanocarrier known as a polymersome to specifically target a protein in choriocarcinoma cells. Depicted is a polymersome with its methotrexate cargo. Illustration by Parinaz Ghanbari. Image Credit: Parinaz Ghanbari

Improved Treatment Method for Rare Pregnancy-Related Cancer

PORTLAND, Ore. – A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other…